Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Natalia Reoutova, 07 Jan 2020

A prospective cohort study of mothers taking antiepileptic drugs (AEDs) and their breastfed infants has found substantially lower AED concentrations in infant vs maternal blood, with nearly half of all obtained AED concentrations in nursing infants being less than the lower limit of quantification (LLoQ).

6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Prelacteal, early formula feeding in infants carries increased hospitalization hazard

23 Oct 2019

Prelacteal and early formula feeding may be detrimental to infants, contributing to an increase in the risk of infection and hospital admission, as shown in a recent study.

The study involved 2,030 pregnant women at 24–28 weeks of gestation who were followed at hospital discharge, 1, 3, 6 and 12 months postpartum. Main outcome measures were rates of infant hospitalization, diarrhoea and lower respiratory tract infection during the first 12 months.

The final analysis included 1,709 infants, among whom 25.5 percent experienced diarrhoea, with 24.8 percent having at least one episode. Almost half (47.6 percent) of the babies developed lower respiratory tract infection by 12 months.

Before hospital discharge, the prevalence of prelacteal feeding was high at 56.5 percent, while formula feeding was common at 79.5 percent.

Multivariate regression models showed that compared with exclusive breastfeeding, both prelacteal feeding and formula feeding before hospital discharge were associated with an elevated risk of adverse health outcomes, particularly hospitalization by 12 months (adjusted odds ratios, 1.43, 95 percent CI, 1.09–1.88 and 1.48, 1.07–2.05, respectively).

The present data point to the importance of providing exclusive breastfeeding by mothers to avoid the adverse consequences of giving formula milk and prelacteal foods, researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Natalia Reoutova, 07 Jan 2020

A prospective cohort study of mothers taking antiepileptic drugs (AEDs) and their breastfed infants has found substantially lower AED concentrations in infant vs maternal blood, with nearly half of all obtained AED concentrations in nursing infants being less than the lower limit of quantification (LLoQ).

6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.